These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23300450)

  • 21. Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition.
    Tellam J; Sherritt M; Thomson S; Tellam R; Moss DJ; Burrows SR; Wiertz E; Khanna R
    J Biol Chem; 2001 Sep; 276(36):33353-60. PubMed ID: 11435434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1.
    Apcher S; Komarova A; Daskalogianni C; Yin Y; Malbert-Colas L; Fåhraeus R
    J Virol; 2009 Feb; 83(3):1289-98. PubMed ID: 19019958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73.
    Gao J; Coulson JM; Whitehouse A; Blake N
    J Virol; 2009 Jan; 83(1):273-82. PubMed ID: 18945762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing.
    Blake N; Lee S; Redchenko I; Thomas W; Steven N; Leese A; Steigerwald-Mullen P; Kurilla MG; Frappier L; Rickinson A
    Immunity; 1997 Dec; 7(6):791-802. PubMed ID: 9430224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.
    Murat P; Zhong J; Lekieffre L; Cowieson NP; Clancy JL; Preiss T; Balasubramanian S; Khanna R; Tellam J
    Nat Chem Biol; 2014 May; 10(5):358-64. PubMed ID: 24633353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing.
    Kwun HJ; da Silva SR; Shah IM; Blake N; Moore PS; Chang Y
    J Virol; 2007 Aug; 81(15):8225-35. PubMed ID: 17522213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells.
    Ito Y; Demachi-Okamura A; Ohta R; Akatsuka Y; Nishida K; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    J Gen Virol; 2007 Mar; 88(Pt 3):770-780. PubMed ID: 17325349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.
    Tellam J; Smith C; Rist M; Webb N; Cooper L; Vuocolo T; Connolly G; Tscharke DC; Devoy MP; Khanna R
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9319-24. PubMed ID: 18591662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nascent polypeptide-associated complex (NAC) controls translation initiation in cis by recruiting nucleolin to the encoding mRNA.
    Zheng AJL; Thermou A; Daskalogianni C; Malbert-Colas L; Karakostis K; Le Sénéchal R; Trang Dinh V; Tovar Fernandez MC; Apcher S; Chen S; Blondel M; Fahraeus R
    Nucleic Acids Res; 2022 Sep; 50(17):10110-10122. PubMed ID: 36107769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
    Levitskaya J; Sharipo A; Leonchiks A; Ciechanover A; Masucci MG
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12616-21. PubMed ID: 9356498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a naturally processed HLA-DR-restricted T-helper epitope in Epstein-Barr virus nuclear antigen type 1.
    Krüger S; Schroers R; Rooney CM; Gahn B; Chen SY
    J Immunother; 2003; 26(3):212-21. PubMed ID: 12806275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.
    Marescotti D; Destro F; Baldisserotto A; Marastoni M; Coppotelli G; Masucci M; Gavioli R
    Immunology; 2010 Mar; 129(3):386-95. PubMed ID: 19922423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.
    Destro F; Sforza F; Sicurella M; Marescotti D; Gallerani E; Baldisserotto A; Marastoni M; Gavioli R
    Immunology; 2011 May; 133(1):105-14. PubMed ID: 21342184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoiding proteasomal processing: the case of EBNA1.
    Dantuma NP; Sharipo A; Masucci MG
    Curr Top Microbiol Immunol; 2002; 269():23-36. PubMed ID: 12224511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
    Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A yeast model for the mechanism of the Epstein-Barr virus immune evasion identifies a new therapeutic target to interfere with the virus stealthiness.
    Lista MJ; Martins RP; Angrand G; Quillévéré A; Daskalogianni C; Voisset C; Teulade-Fichou MP; Fåhraeus R; Blondel M
    Microb Cell; 2017 Aug; 4(9):305-307. PubMed ID: 28913345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours.
    Snudden DK; Smith PR; Lai D; Ng MH; Griffin BE
    Oncogene; 1995 Apr; 10(8):1545-52. PubMed ID: 7731709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function.
    Yates JL; Camiolo SM; Ali S; Ying A
    Virology; 1996 Aug; 222(1):1-13. PubMed ID: 8806482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.